To Market, To Market: Ontario, Canada’s vision to improve commercialization of healthcare research

Transforming medical research findings into viable commercial enterprises is a persistent challenge. Ontario, Canada, has deployed several approaches that could be applied in other regions. The provincial government has created R&D tax incentives, investment funds and commercialization incubators, along with streamlining clinical trials regulatory processes, to increase speed-to-market for medical biotechnology innovations. By creating supportive government policies, providing seed capital, and promoting partnerships between research institutions and industry, Ontario helps start-ups such as ApneaDX and OtoSim attract follow-on funding and access markets.



Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog